Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial

BACKGROUND: Psoriasis is an immune-mediated chronic inflammatory skin disorder for which several targeted biologic therapies became available in the last 10 years. Data from patients with rheumatoid arthritis revealed that dose tapering combined with tight control of disease activity is successful....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Dermatol
Hlavní autoři: Atalay, Selma, van den Reek, Juul M. P. A., van Vugt, Lieke J., Otero, Marisol E., van de Kerkhof, Peter C. M., den Broeder, Alfons A., Kievit, Wietske, de Jong, Elke M. G. J.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5422943/
https://ncbi.nlm.nih.gov/pubmed/28482858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12895-017-0057-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky